Manning & Napier Group, LLC Bristol Myers Squibb CO Transaction History

Manning & Napier Group, LLC

$8.76 Billion
Q1 2024

A detailed history of Manning & Napier Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Manning & Napier Group, LLC holds 425,781 shares of BMY stock, worth $24.8 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

425,781

Previous 462,251 7.89%

Holding current value

$24.8 Million

Previous $23.7 Million 2.65%

% of portfolio

0.26%

Previous 0.28%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$47.98 - $54.4 $1.75 Million - $1.98 Million	-36,470 Reduced 7.89%	425,781 $23.1 Million
Q4 2023 Jan 19, 2024	SELL	$48.48 - $57.85 $3.48 Million - $4.15 Million	-71,686 Reduced 13.43%	462,251 $23.7 Million
Q3 2023 Oct 20, 2023	SELL	$57.89 - $64.73 $1.07 Million - $1.2 Million	-18,539 Reduced 3.36%	533,937 $31 Million
Q2 2023 Jul 26, 2023	BUY	$63.71 - $70.74 $3.88 Million - $4.31 Million	60,974 Added 12.41%	552,476 $35.3 Million
Q1 2023 Apr 17, 2023	SELL	$65.71 - $74.53 $22,604 - $25,638	-344 Reduced 0.07%	491,502 $34.1 Million
Q4 2022 Jan 26, 2023	SELL	$68.48 - $81.09 $304,393 - $360,445	-4,445 Reduced 0.9%	491,846 $0
Q3 2022 Oct 18, 2022	SELL	$0.13 - $76.84 $1,201 - $710,385	-9,245 Reduced 1.83%	496,291 $35.3 Million
Q2 2022 Jul 12, 2022	SELL	$72.62 - $79.98 $8.6 Million - $9.47 Million	-118,439 Reduced 18.98%	505,536 $38.9 Million
Q1 2022 Apr 19, 2022	SELL	$61.48 - $73.72 $2.99 Million - $3.59 Million	-48,695 Reduced 7.24%	623,975 $45.6 Million
Q4 2021 Jan 27, 2022	SELL	$53.63 - $62.52 $1.83 Million - $2.13 Million	-34,139 Reduced 4.83%	672,670 $41.9 Million
Q3 2021 Oct 14, 2021	SELL	$59.17 - $69.31 $439,455 - $514,765	-7,427 Reduced 1.04%	706,809 $41.8 Million
Q2 2021 Jul 19, 2021	BUY	$61.91 - $67.42 $6.81 Million - $7.41 Million	109,944 Added 18.19%	714,236 $47.7 Million
Q1 2021 Apr 28, 2021	BUY	$59.34 - $66.74 $875,680 - $984,882	14,757 Added 2.5%	604,292 $38.1 Million
Q4 2020 Jan 20, 2021	SELL	$57.74 - $65.43 $2.49 Million - $2.82 Million	-43,038 Reduced 6.8%	589,535 $36.6 Million
Q3 2020 Oct 29, 2020	BUY	$57.43 - $63.64 $337,401 - $373,885	5,875 Added 0.94%	632,573 $38.1 Million
Q2 2020 Jul 10, 2020	BUY	$54.82 - $64.09 $1.86 Million - $2.18 Million	33,979 Added 5.73%	626,698 $36.8 Million
Q1 2020 Apr 13, 2020	BUY	$46.4 - $67.43 $4.12 Million - $5.98 Million	88,717 Added 17.6%	592,719 $33 Million
Q4 2019 Jan 10, 2020	BUY	$49.21 - $64.19 $1.58 Million - $2.06 Million	32,033 Added 6.79%	504,002 $32.4 Million
Q3 2019 Oct 10, 2019	BUY	$42.77 - $50.71 $89,645 - $106,288	2,096 Added 0.45%	471,969 $23.9 Million
Q2 2019 Jul 24, 2019	BUY	$44.62 - $49.34 $5.52 Million - $6.1 Million	123,718 Added 35.74%	469,873 $21.3 Million
Q1 2019 Apr 10, 2019	SELL	$45.12 - $53.8 $55 Million - $65.5 Million	-1,217,950 Reduced 77.87%	346,155 $16.5 Million
Q4 2018 Jan 24, 2019	SELL	$48.76 - $63.23 $312,941 - $405,810	-6,418 Reduced 0.41%	1,564,105 $81.3 Million
Q3 2018 Oct 10, 2018	BUY	$55.19 - $62.25 $960,637 - $1.08 Million	17,406 Added 1.12%	1,570,523 $97.5 Million
Q2 2018 Jul 13, 2018	BUY	$50.53 - $62.98 $11.7 Million - $14.5 Million	230,707 Added 17.45%	1,553,117 $85.9 Million
Q1 2018 May 01, 2018	SELL	$59.92 - $68.98 $28.5 Million - $32.8 Million	-476,091 Reduced 26.47%	1,322,410 $83.6 Million
Q4 2017 Feb 05, 2018	BUY	$59.94 - $65.35 $108 Million - $118 Million	1,798,501	1,798,501 $110 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Group, LLC with notifications on news.

Account

Manning & Napier Group, LLC Bristol Myers Squibb CO Transaction History